Table 3. Clinical Courses and Outcomes.
Variable | SRC group (n=15) | NMAC group (n=75) | P-value* |
---|---|---|---|
Follow-up duration (mo), median (range) | 30.09 (6.74-112.07) | 43.73 (7.75-136.28) | 0.141 |
Adjuvant chemotherapy | 14 (93.3) | 70 (93.3) | 1.000 |
Recurrence after resection | 5 (33.3) | 8 (10.7) | 0.038 |
Mortality | 6 (40.0) | 5 (6.7) | 0.004 |
Values are presented as n (%).
*Conditional logistic regression that accounted for the clustering of matched pairs.
SRC, signet-ring-cell carcinoma; NMAC, non-mucinous adenocarcinoma.